Where the Street stands
These are third-party analyst opinions from named firms, not advice, and not a prediction. How we score this
19 firms currently rating it, weighted by track record.
The 19 firms with a track record here beat the S&P 43% of the time over 12 months.
Pro: see the crowd-vs-sharp split for IBMAnalysts rate IBM a Buy with an average price target of $245.33, implying 8.3% upside from the current $226.44, though ratings are mixed: 14 analysts rate buy or stronger versus 9 on hold and 2 on sell. Most recent activity shows maintenance from major firms, with JPMorgan upgrading to Overweight on June 23 and HSBC downgrading to Reduce on July 14. The stock trades at a trailing P/E of 20.20 with a forward P/E of 17.19, supported by a net margin of 15.52% and strong ROE of 34.46%, though revenue growth has slowed to 1.10% year-over-year and EPS declined 1.80% year-over-year. With a beta of 0.68, IBM exhibits lower volatility relative to the broader market.
Generated from the data on this page; may contain errors. Analyst opinions belong to the named firms. Informational only, not investment advice.
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 31, 2026 | Susquehanna | ○ Maintained | |
| Jul 24, 2026 | Citigroup | ○ Maintained |
Create a free account to unlock all analyst ratings, key stats, and news. No credit card, takes 30 seconds.
Sign up free